Prof. Dr. Edgar Dahl (PhD)
Prof. Dr. Edgar Dahl (PhD)
Professor of Tumor Pathology, RWTH Aachen University
Verified email at - Homepage
Cited by
Cited by
Pax genes and organogenesis
E Dahl, H Koseki, R Balling
Bioessays 19 (9), 755-765, 1997
Macrophage migration inhibitory factor (MIF) promotes cell survival by activation of the Akt pathway and role for CSN5/JAB1 in the control of autocrine MIF activity
H Lue, M Thiele, J Franz, E Dahl, S Speckgens, L Leng, ...
Oncogene 26 (35), 5046-5059, 2007
CD24 expression is a new prognostic marker in breast cancer
G Kristiansen, KJ Winzer, E Mayordomo, J Bellach, K Schlüns, C Denkert, ...
Clinical cancer research 9 (13), 4906-4913, 2003
CD24 is expressed in ovarian cancer and is a new independent prognostic marker of patient survival
G Kristiansen, C Denkert, K Schlüns, E Dahl, C Pilarsky, S Hauptmann
The American journal of pathology 161 (4), 1215, 2002
The diversity of connexin genes encoding gap junctional proteins.
K Willecke, H Hennemann, E Dahl, S Jungbluth, R Heynkes
European journal of cell biology 56 (1), 1, 1991
Aberrant methylation of the Wnt antagonist SFRP1 in breast cancer is associated with unfavourable prognosis
J Veeck, D Niederacher, H An, E Klopocki, F Wiesmann, B Betz, O Galm, ...
Oncogene 25 (24), 3479-3488, 2006
Frequent expression loss of Inter-alpha-trypsin inhibitor heavy chain (ITIH) genes in multiple human solid tumors: a systematic expression analysis
A Hamm, J Veeck, N Bektas, PJ Wild, A Hartmann, U Heindrichs, ...
BMC cancer 8, 1-15, 2008
Expression pattern of connexin gene products at the early developmental stages of the mouse cardiovascular system
B Delorme, E Dahl, T Jarry-Guichard, JP Briand, K Willecke, D Gros, ...
Circulation research 81 (3), 423-437, 1997
Expression profiling of microdissected matched prostate cancer samples reveals CD166/MEMD and CD24 as new prognostic markers for patient survival
G Kristiansen, C Pilarsky, C Wissmann, S Kaiser, T Bruemmendorf, ...
The Journal of pathology 205 (3), 359-376, 2004
Molecular cloning and functional expression of mouse connexin-30, a gap junction gene highly expressed in adult brain and skin
E Dahl, D Manthey, Y Chen, HJ Schwarz, YS Chang, PA Lalley, ...
Journal of Biological Chemistry 271 (30), 17903-17910, 1996
Targeting the Wnt pathway in cancer: the emerging role of Dickkopf-3
J Veeck, E Dahl
Biochimica et Biophysica Acta (BBA)-Reviews on Cancer, 2011
Molecular cloning and functional expression of mouse connexin40, a second gap junction gene preferentially expressed in lung
H Hennemann, T Suchyna, H Lichtenberg-Fraté, S Jungbluth, E Dahl, ...
The Journal of cell biology 117 (6), 1299-1310, 1992
Loss of SFRP1 is associated with breast cancer progression and poor prognosis in early stage tumors.
E Klopocki, G Kristiansen, PJ Wild, I Klaman, E Castanos-Velez, G Singer, ...
International journal of oncology 25 (3), 641, 2004
Mouse connexin37: cloning and functional expression of a gap junction gene highly expressed in lung.
K Willecke, R Heynkes, E Dahl, R Stutenkemper, H Hennemann, ...
The Journal of cell biology 114 (5), 1049-1057, 1991
Antifibrotic effects of CXCL9 and its receptor CXCR3 in livers of mice and humans
HE Wasmuth, F Lammert, MM Zaldivar, R Weiskirchen, C Hellerbrand, ...
Gastroenterology 137 (1), 309-319. e3, 2009
The death-domain fold of the ASC PYRIN domain, presenting a basis for PYRIN/PYRIN recognition
E Liepinsh, R Barbals, E Dahl, A Sharipo, E Staub, G Otting
Journal of molecular biology 332 (5), 1155-1163, 2003
Developmental regulation of connexin 40 gene expression in mouse heart correlates with the differentiation of the conduction system
B Delorme, E Dahl, T Jarry‐guichard, I Marics, JP Briand, K Willecke, ...
Developmental Dynamics 204 (4), 358-371, 1995
Deletions of chromosome 8p and loss of sFRP1 expression are progression markers of papillary bladder cancer
R Stoehr, C Wissmann, H Suzuki, R Knuechel, RC Krieg, E Klopocki, ...
Laboratory investigation 84 (4), 465-478, 2004
Molecular profiling of laser-microdissected matched tumor and normal breast tissue identifies karyopherin α2 as a potential novel prognostic marker in breast cancer
E Dahl, G Kristiansen, K Gottlob, I Klaman, E Ebner, B Hinzmann, ...
Clinical Cancer Research 12 (13), 3950-3960, 2006
Targeted disruption of Pax1 defines its null phenotype and proves haploinsufficiency
B Wilm, E Dahl, H Peters, R Balling, K Imai
Proceedings of the National Academy of Sciences 95 (15), 8692-8697, 1998
The system can't perform the operation now. Try again later.
Articles 1–20